🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study is studying a research drug called AZD6738 as a possibl...
Status
Active Not Recruiting
Location
BIDMC
Start Date
2019-08-05
Trial ID
NCT03770429
Treatments Being Tested
This study is a single arm, multi-center phase II study of durvalumab and A...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2020-06-17
Trial ID
NCT04361825
Treatments Being Tested
This phase II trial studies how well olaparib and ceralasertib (AZD6738) wo...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-01-30
Trial ID
NCT03878095
To assess the effect of AZD6738 and Durvalumab combination or AZD6738 and O...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2020-06-25
Trial ID
NCT04298021
Treatments Being Tested
This biomarker study has been designed to assess the effects of different a...
Status
Completed
Location
Research Site
Start Date
2017-09-18
Trial ID
NCT03022409
Treatments Being Tested
ATARI trial tests the ATR inhibitor drug ceralasertib (AZD6738) alone and i...
Status
Active Not Recruiting
Location
The Ottawa Hospital Cancer Centre
Start Date
2019-11-27
Trial ID
NCT04065269
Treatments Being Tested
This phase II trial studies how well ceralasertib, am Ataxia telangiectasia...
Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2019-01-17
Trial ID
NCT03682289
Treatments Being Tested
Aim of this phase 2 study is to explore the safety and efficacy of thoracic...
Status
Recruiting
Location
ASST degli Spedali Civili di Brescia
Start Date
2025-08-07
Trial ID
NCT06680050
Treatments Being Tested
This phase II study assesses the efficacy of the combination of olaparib wi...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2018-12-12
Trial ID
NCT03801369
Treatments Being Tested
This phase III trial compares the effect of adding AZD6738 to durvalumab ve...
Status
Active Not Recruiting
Location
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Start Date
2025-08-07
Trial ID
NCT06732401
Treatments Being Tested